Patents by Inventor Adam Belley

Adam Belley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of inhibiting and treating biofilms using glycopeptide antibiotics
    Patent number: 10201587
    Abstract: The present invention is directed to methods of inhibition, delay of formation, treatment, prophylaxis and/or prevention of infections caused by bacteria that exhibit tolerance to antimicrobial agents, including slow growing, stationary-phase and biofilm forming bacteria, through the use of glycopeptide antibiotics, such as oritavancin.
    Type: Grant
    Filed: April 2, 2009
    Date of Patent: February 12, 2019
    Assignee: MELINTA THERAPEUTICS, INC.
    Inventors: Eve Neesham-Grenon, Gregory Moeck, Adam Belley, Thomas R. Parr, Jr., Adel Rafai Far
  • Disk diffusion assay for oritavancin
    Patent number: 8815535
    Abstract: The present invention is directed to a disk diffusion assay for determining susceptibility of bacteria to a glycopeptide antibiotic. The assay includes improvements over conventional assays due to the inclusion of polysorbate 80 and Span 80 in the antibacterial solution used to impregnate paper disks used in the assay.
    Type: Grant
    Filed: July 26, 2012
    Date of Patent: August 26, 2014
    Assignee: The Medicines Company
    Inventor: Adam Belley
  • DISK DIFFUSION ASSAY FOR ORITAVANCIN
    Publication number: 20130029371
    Abstract: The present invention is directed to a disk diffusion assay for determining susceptibility of bacteria to a glycopeptide antibiotic. The assay includes improvements over conventional assays due to the inclusion of polysorbate 80 and Span 80 in the antibacterial solution used to impregnate paper disks used in the assay.
    Type: Application
    Filed: July 26, 2012
    Publication date: January 31, 2013
    Applicant: THE MEDICINES COMPANY
    Inventor: Adam BELLEY
  • METHODS OF INHIBITING AND TREATING BIOFILMS USING GLYCOPEPTIDE ANTIBIOTICS
    Publication number: 20110046041
    Abstract: The present invention is directed to methods of inhibition, delay of formation, treatment, prophylaxis and/or prevention of infections caused by bacteria that exhibit tolerance to antimicrobial agents, including slow growing, stationary-phase and biofilm forming bacteria, through the use of glycopeptide antibiotics, such as oritavancin.
    Type: Application
    Filed: April 2, 2009
    Publication date: February 24, 2011
    Applicant: TARGANTA THERAPEUTICS CORP.
    Inventors: Eve Neesham-Grenon, Gregory Moeck, Adam Belley, Thomas R. Parr, JR., Adel Rafai Far